首页> 外文期刊>Journal of Nanjing Medical University >Prognostic Factors in Patients with Pancreatic Carcinoma
【24h】

Prognostic Factors in Patients with Pancreatic Carcinoma

机译:胰腺癌患者的预后因素

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To evaluate the major prognostic factors in patients with pancreatic carcinoma. Methods: 113 cases of a particular disease were retrospectively analysed and 9 factors for prognosis were studied by mul-tivaritate analysis with Cox proportional hazards survival model. Survival rate was calculated by Kaplan-Meier estimation. Results: In this group, survival time was 0.1 to 82 months, and the median survival time was 3 months. Overall survival rates at month 6,12,18,36 were 35.6%, 20.3%, 15.9% and 6.2%, respectively. Multivariate analyses revealed significant prognostic factors as follows: jaundice,metastasis, therapy method and synthetic therapy. Conclusion: The prognosis of pancreatic carcinoma is determined by various factors. Jaundice and metastasis are independent predictors of poor survival. Radical operation and synthetic therapy will improve the prognosis.
机译:目的:评估胰腺癌患者的主要预后因素。方法:回顾性分析113例特定疾病,并采用Cox比例风险生存模型进行多变量分析,探讨9个预后因素。通过Kaplan-Meier估计计算存活率。结果:该组生存时间为0.1至82个月,中位生存时间为3个月。在第6,12,18,36个月的总生存率分别为35.6%,20.3%,15.9%和6.2%。多因素分析显示以下重要的预后因素:黄疸,转移,治疗方法和综合治疗。结论:胰腺癌的预后取决于多种因素。黄疸和转移是不良生存的独立预测因子。根治性手术和综合治疗将改善预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号